{"name":"Clover Biopharmaceuticals AUS Pty","slug":"clover-biopharmaceuticals-aus-pty","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1500000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"AREXVY","genericName":"AREXVY","slug":"arexvy","revenue":1500000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":1500000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AREXVY","genericName":"AREXVY","slug":"arexvy","indication":"Other","status":"marketed","revenue":1500000000}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Comirnaty Vaccine","genericName":"Comirnaty Vaccine","slug":"comirnaty-vaccine","indication":"Prevention of COVID-19 disease caused by SARS-CoV-2","status":"phase_3"},{"name":"CoronaVac Vaccine","genericName":"CoronaVac Vaccine","slug":"coronavac-vaccine","indication":"Prevention of COVID-19 in adults and adolescents","status":"phase_3"},{"name":"Vaxzevria Vaccine","genericName":"Vaxzevria Vaccine","slug":"vaxzevria-vaccine","indication":"COVID-19 prevention","status":"phase_3"}]}],"pipeline":[{"name":"AREXVY","genericName":"AREXVY","slug":"arexvy","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Comirnaty Vaccine","genericName":"Comirnaty Vaccine","slug":"comirnaty-vaccine","phase":"phase_3","mechanism":"Comirnaty is an mRNA vaccine that instructs cells to produce the SARS-CoV-2 spike protein, triggering an immune response to prevent COVID-19 infection.","indications":["Prevention of COVID-19 disease caused by SARS-CoV-2"],"catalyst":""},{"name":"CoronaVac Vaccine","genericName":"CoronaVac Vaccine","slug":"coronavac-vaccine","phase":"phase_3","mechanism":"CoronaVac is an inactivated SARS-CoV-2 vaccine that stimulates the immune system to produce antibodies and cellular immunity against the virus.","indications":["Prevention of COVID-19 in adults and adolescents"],"catalyst":""},{"name":"Vaxzevria Vaccine","genericName":"Vaxzevria Vaccine","slug":"vaxzevria-vaccine","phase":"phase_3","mechanism":"Vaxzevria Vaccine works by stimulating the body's immune system to produce a specific response against the SARS-CoV-2 virus.","indications":["COVID-19 prevention"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-07","type":"earnings","source":"simplywall.st","summary":"Clover Biopharmaceuticals, Ltd.'s (HKG:2197) market cap rose HK$311m last week; retail investors who hold 53% profited and so did insiders - simplywall.st","headline":"Clover Biopharmaceuticals, Ltd.'s (HKG:2197) market cap rose HK$311m last week; retail investors who hold 53% profited a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNTzJmSEtSVk5ZSGRzLS1FaVRUb0pnei1XLVkwMVRpbW1WQkJhVVowaF9DTWd3UDF0THltMHhjV1ZRejVpUzZkc1hRQWJPTm5vOXk1MThfYW40MEpzbkRTVGNKMjRQeWp1QThJRTVCZ29HdzlmbGwybGZpa0J6MFFqbkZnSWoxQ3padU9QU29kYjA4WHdCZkNuUnJzQTV2ZU1PUm8xbHl1ekNpQ0NKMzZWaGlTcTBBUU1VM0J4cU8tR0J3TzZ5aFJXOFpjcXdxQTFzM0hWZW5TUU9MeUlPVkZvVA?oc=5","date":"2021-01-07","type":"regulatory","source":"fda.gov.ph","summary":"Press Statement || Updates on Applications for Conduct of Clinical Trials and Emergency Use Authorization of COVID-19 Vaccines - fda.gov.ph","headline":"Press Statement || Updates on Applications for Conduct of Clinical Trials and Emergency Use Authorization of COVID-19 Va","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQajMxT1g5UWtQQW5LUExaY1FHQ3FOVXpkTnlHbC1PNVpRUXRjbHRYM0pxQjVVa2ZobzN4QmROTENIM3IzaVEta0ViY19uWERCVmd6ZGlveWhtbHFvWThiZjNLUFFMWWVJbVdBb3NxSnc0cHJHd3BIa0VGWUFNTi1lck1QRllETElYLVZpZUlfalo3SFVDVXc0X0pXRUZYZS16UVg5WlVPbUU0cGpKSnc?oc=5","date":"2020-04-26","type":"deal","source":"CEPI","summary":"CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals' Australian Subsidiary - CEPI","headline":"CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals' Australian Subsidiary","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":1,"phase_3":3},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}